MAP2K7 and lung adenocarcinoma: To clarify whether the cell response to MEK/ERK inhibition by PD0325901 is specific for the ERas-engineered cell line or inhibition of MEK/ERK signaling would successfully eliminate also other Ras-expressing senescent tumor cells, we used Ki-Ras mutated A549 human lung adenocarcinoma cells.